Amr Hassan

The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke et al. · Nature · 2017 · 574 citations

Molecular Pharmacology, Drug Target, Medicine +3

Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1

Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini et al. · Journal of Medicinal Chemistry · 2018 · 432 citations · Full text

Drug Target, Mixed-phenotype Acute Leukemia, Molecular Biology +16

Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors

Veronica Gibaja, F Shen, J Harari et al. · Oncogene · 2015 · 142 citations · Full text

Genetics, Molecular Biology, Molecular Genetics +21

Investigation of Angiogenesis and Wound Healing Potential Mechanisms of Zinc Oxide Nanorods

Amr Hassan, Dalia Elebeedy, Emadeldin R. Matar et al. · Frontiers in Pharmacology · 2021 · 59 citations · Full text

Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies

Rehab F. Taher, Ahmed A. Al‐Karmalawy, Ahmed I. Abd El Maksoud et al. · Journal of Herbmed Pharmacology · 2021 · 58 citations · Full text

F. Muell, Molecular Docking Studies, Medicinal Chemistry +14